CBIO logo

Catalyst Biosciences (CBIO) Net Income

Annual Net Income

-$8.24 M
+$79.69 M+90.63%

31 December 2022

CBIO Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$1.58 M
+$896.00 K+36.25%

30 September 2023

CBIO Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$44.24 M
+$3.31 M+6.96%

30 September 2023

CBIO TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBIO Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+85.3%+93.8%+48.9%
5 y5 years+72.6%+87.6%+15.6%

CBIO Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-175.6%-103.1%-365.1%

Catalyst Biosciences Net Income History

DateAnnualQuarterlyTTM
Sept 2023
-
-$1.58 M(-36.2%)
-$44.24 M(-7.0%)
June 2023
-
-$2.47 M(-1050.8%)
-$47.55 M(-825.5%)
Mar 2023
-
$260.00 K(-100.6%)
$6.55 M(-179.5%)
Dec 2022
-$8.24 M(-90.6%)
-$40.45 M(+728.3%)
-$8.24 M(-169.4%)
Sept 2022
-
-$4.88 M(-109.5%)
$11.88 M(-240.3%)
June 2022
-
$51.63 M(-455.2%)
-$8.47 M(-89.4%)
Mar 2022
-
-$14.54 M(-28.5%)
-$80.03 M(-9.0%)
Dec 2021
-$87.93 M(+56.4%)
-$20.33 M(-19.5%)
-$87.93 M(+1.6%)
Sept 2021
-
-$25.24 M(+26.6%)
-$86.51 M(+11.9%)
June 2021
-
-$19.93 M(-11.2%)
-$77.31 M(+3.6%)
Mar 2021
-
-$22.44 M(+18.7%)
-$74.63 M(+32.7%)
Dec 2020
-$56.24 M(+1.9%)
-$18.91 M(+17.9%)
-$56.24 M(+10.4%)
Sept 2020
-
-$16.03 M(-7.0%)
-$50.94 M(+7.0%)
June 2020
-
-$17.25 M(+325.6%)
-$47.62 M(+7.9%)
Mar 2020
-
-$4.05 M(-70.2%)
-$44.15 M(-20.0%)
Dec 2019
-$55.18 M(+83.6%)
-$13.61 M(+7.1%)
-$55.18 M(+5.3%)
Sept 2019
-
-$12.71 M(-7.8%)
-$52.41 M(+10.6%)
June 2019
-
-$13.78 M(-8.6%)
-$47.39 M(+18.2%)
Mar 2019
-
-$15.08 M(+39.2%)
-$40.10 M(+33.4%)
Dec 2018
-$30.05 M(+39.4%)
-$10.84 M(+40.9%)
-$30.05 M(+20.4%)
Sept 2018
-
-$7.69 M(+18.7%)
-$24.97 M(+8.2%)
June 2018
-
-$6.48 M(+28.6%)
-$23.07 M(+2.7%)
Mar 2018
-
-$5.04 M(-12.4%)
-$22.46 M(+4.2%)
Dec 2017
-$21.56 M(+27.2%)
-$5.75 M(-0.7%)
-$21.56 M(+10.2%)
Sept 2017
-
-$5.79 M(-1.4%)
-$19.56 M(+5.5%)
June 2017
-
-$5.88 M(+42.0%)
-$18.54 M(+6.0%)
Mar 2017
-
-$4.14 M(+10.3%)
-$17.49 M(+3.2%)
Dec 2016
-$16.95 M(+14.8%)
-$3.75 M(-21.4%)
-$16.95 M(-7.5%)
Sept 2016
-
-$4.77 M(-1.3%)
-$18.33 M(-1.5%)
June 2016
-
-$4.83 M(+34.5%)
-$18.61 M(+2.7%)
Mar 2016
-
-$3.59 M(-30.0%)
-$18.11 M(-14.9%)
Dec 2015
-$14.76 M(-54.7%)
-$5.13 M(+1.6%)
-$21.27 M(+2.4%)
Sept 2015
-
-$5.05 M(+16.5%)
-$20.77 M(+0.9%)
June 2015
-
-$4.34 M(-35.8%)
-$20.58 M(-15.6%)
Mar 2015
-
-$6.75 M(+45.9%)
-$24.38 M(-25.3%)
Dec 2014
-$32.62 M(-30.2%)
-$4.63 M(-4.8%)
-$32.62 M(-21.1%)
Sept 2014
-
-$4.86 M(-40.3%)
-$41.36 M(-16.3%)
June 2014
-
-$8.14 M(-45.8%)
-$49.40 M(-7.9%)
Mar 2014
-
-$15.00 M(+12.2%)
-$53.64 M(+14.8%)
DateAnnualQuarterlyTTM
Dec 2013
-$46.70 M(+567.4%)
-$13.37 M(+3.6%)
-$46.70 M(-5.1%)
Sept 2013
-
-$12.90 M(+4.3%)
-$49.21 M(+11.4%)
June 2013
-
-$12.37 M(+53.4%)
-$44.19 M(+155.1%)
Mar 2013
-
-$8.07 M(-49.2%)
-$17.32 M(+147.5%)
Dec 2012
-$7.00 M(-18.0%)
-$15.87 M(+101.4%)
-$7.00 M(+650.1%)
Sept 2012
-
-$7.88 M(-154.4%)
-$933.00 K(-55.7%)
June 2012
-
$14.49 M(+541.5%)
-$2.11 M(-88.8%)
Mar 2012
-
$2.26 M(-123.0%)
-$18.86 M(+121.1%)
Dec 2011
-$8.53 M(-178.3%)
-$9.80 M(+8.3%)
-$8.53 M(+860.5%)
Sept 2011
-
-$9.05 M(+301.2%)
-$888.00 K(-108.3%)
June 2011
-
-$2.26 M(-117.9%)
$10.65 M(-36.2%)
Mar 2011
-
$12.59 M(-681.7%)
$16.69 M(+53.1%)
Dec 2010
$10.90 M(-127.7%)
-$2.16 M(-187.0%)
$10.90 M(-181.7%)
Sept 2010
-
$2.49 M(-34.3%)
-$13.34 M(-7.9%)
June 2010
-
$3.78 M(-44.3%)
-$14.50 M(-48.1%)
Mar 2010
-
$6.79 M(-125.7%)
-$27.93 M(-29.1%)
Dec 2009
-$39.40 M(+53.6%)
-$26.41 M(-2079.5%)
-$39.40 M(+113.9%)
Sept 2009
-
$1.33 M(-113.8%)
-$18.43 M(-32.8%)
June 2009
-
-$9.65 M(+106.4%)
-$27.41 M(+11.6%)
Mar 2009
-
-$4.68 M(-13.9%)
-$24.56 M(-4.3%)
Dec 2008
-$25.66 M(-8.6%)
-$5.43 M(-29.0%)
-$25.66 M(-8.0%)
Sept 2008
-
-$7.65 M(+12.4%)
-$27.88 M(+1.0%)
June 2008
-
-$6.80 M(+17.7%)
-$27.60 M(-5.0%)
Mar 2008
-
-$5.78 M(-24.4%)
-$29.06 M(+3.5%)
Dec 2007
-$28.07 M(-1439.0%)
-$7.65 M(+3.7%)
-$28.07 M(+677.8%)
Sept 2007
-
-$7.37 M(-10.8%)
-$3.61 M(+226.8%)
June 2007
-
-$8.26 M(+72.4%)
-$1.10 M(-143.5%)
Mar 2007
-
-$4.79 M(-128.5%)
$2.54 M(+21.2%)
Dec 2006
$2.10 M(-107.2%)
$16.82 M(-445.6%)
$2.10 M(-109.9%)
Sept 2006
-
-$4.87 M(+5.4%)
-$21.25 M(-8.8%)
June 2006
-
-$4.62 M(-11.9%)
-$23.30 M(-13.0%)
Mar 2006
-
-$5.24 M(-19.8%)
-$26.79 M(-7.6%)
Dec 2005
-$28.99 M(+20.7%)
-$6.53 M(-5.7%)
-$28.99 M(+29.1%)
Sept 2005
-
-$6.92 M(-14.6%)
-$22.46 M(+44.5%)
June 2005
-
-$8.11 M(+9.0%)
-$15.54 M(+109.0%)
Mar 2005
-
-$7.44 M
-$7.44 M
Dec 2004
-$24.03 M(+23.9%)
-
-
Dec 2003
-$19.39 M(-8.0%)
-
-
Dec 2002
-$21.07 M(+188.6%)
-
-
Dec 2001
-$7.30 M
-
-

FAQ

  • What is Catalyst Biosciences annual net profit?
  • What is the all time high annual net income for Catalyst Biosciences?
  • What is Catalyst Biosciences quarterly net profit?
  • What is the all time high quarterly net income for Catalyst Biosciences?
  • What is Catalyst Biosciences TTM net profit?
  • What is the all time high TTM net income for Catalyst Biosciences?

What is Catalyst Biosciences annual net profit?

The current annual net income of CBIO is -$8.24 M

What is the all time high annual net income for Catalyst Biosciences?

Catalyst Biosciences all-time high annual net profit is $10.90 M

What is Catalyst Biosciences quarterly net profit?

The current quarterly net income of CBIO is -$1.58 M

What is the all time high quarterly net income for Catalyst Biosciences?

Catalyst Biosciences all-time high quarterly net profit is $51.63 M

What is Catalyst Biosciences TTM net profit?

The current TTM net income of CBIO is -$44.24 M

What is the all time high TTM net income for Catalyst Biosciences?

Catalyst Biosciences all-time high TTM net profit is $16.69 M